Cargando…

The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor

[Image: see text] Factor inhibiting HIF (FIH) is a cellular O(2)-sensing enzyme, which hydroxylates the hypoxia inducible factor-1α. Previously reported inverse solvent kinetic isotope effects indicated that FIH limits its overall turnover through an O(2) activation step ( J. A. Hangasky, E. Saban,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hangasky, John A., Gandhi, Hasand, Valliere, Meaghan A., Ostrom, Nathaniel E., Knapp, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283935/
https://www.ncbi.nlm.nih.gov/pubmed/25423620
http://dx.doi.org/10.1021/bi501246v
_version_ 1782351344035692544
author Hangasky, John A.
Gandhi, Hasand
Valliere, Meaghan A.
Ostrom, Nathaniel E.
Knapp, Michael J.
author_facet Hangasky, John A.
Gandhi, Hasand
Valliere, Meaghan A.
Ostrom, Nathaniel E.
Knapp, Michael J.
author_sort Hangasky, John A.
collection PubMed
description [Image: see text] Factor inhibiting HIF (FIH) is a cellular O(2)-sensing enzyme, which hydroxylates the hypoxia inducible factor-1α. Previously reported inverse solvent kinetic isotope effects indicated that FIH limits its overall turnover through an O(2) activation step ( J. A. Hangasky, E. Saban, and M. J. Knapp (2013) Biochemistry52, 1594−160223351038). Here we characterize the rate-limiting step for O(2) activation by FIH using a suite of mechanistic probes on the second order rate constant k(cat)/K(M(O(2))). Steady-state kinetics showed that the rate constant for O(2) activation was slow (k(cat)/K(M(O(2)))(app) = 3500 M(–1) s(–1)) compared with other non-heme iron oxygenases, and solvent viscosity assays further excluded diffusional encounter with O(2) from being rate limiting on k(cat)/K(M(O(2))). Competitive oxygen-18 kinetic isotope effect measurements ((18)k(cat)/K(M(O(2))) = 1.0114(5)) indicated that the transition state for O(2) activation resembled a cyclic peroxohemiketal, which precedes the formation of the ferryl intermediate observed in related enzymes. We interpret this data to indicate that FIH limits its overall activity at the point of the nucleophilic attack of Fe-bound O(2)(—) on the C-2 carbon of αKG. Overall, these results show that FIH follows the consensus mechanism for αKG oxygenases, suggesting that FIH may be an ideal enzyme to directly access steps involved in O(2) activation among the broad family of αKG oxygenases.
format Online
Article
Text
id pubmed-4283935
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42839352015-11-25 The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor Hangasky, John A. Gandhi, Hasand Valliere, Meaghan A. Ostrom, Nathaniel E. Knapp, Michael J. Biochemistry [Image: see text] Factor inhibiting HIF (FIH) is a cellular O(2)-sensing enzyme, which hydroxylates the hypoxia inducible factor-1α. Previously reported inverse solvent kinetic isotope effects indicated that FIH limits its overall turnover through an O(2) activation step ( J. A. Hangasky, E. Saban, and M. J. Knapp (2013) Biochemistry52, 1594−160223351038). Here we characterize the rate-limiting step for O(2) activation by FIH using a suite of mechanistic probes on the second order rate constant k(cat)/K(M(O(2))). Steady-state kinetics showed that the rate constant for O(2) activation was slow (k(cat)/K(M(O(2)))(app) = 3500 M(–1) s(–1)) compared with other non-heme iron oxygenases, and solvent viscosity assays further excluded diffusional encounter with O(2) from being rate limiting on k(cat)/K(M(O(2))). Competitive oxygen-18 kinetic isotope effect measurements ((18)k(cat)/K(M(O(2))) = 1.0114(5)) indicated that the transition state for O(2) activation resembled a cyclic peroxohemiketal, which precedes the formation of the ferryl intermediate observed in related enzymes. We interpret this data to indicate that FIH limits its overall activity at the point of the nucleophilic attack of Fe-bound O(2)(—) on the C-2 carbon of αKG. Overall, these results show that FIH follows the consensus mechanism for αKG oxygenases, suggesting that FIH may be an ideal enzyme to directly access steps involved in O(2) activation among the broad family of αKG oxygenases. American Chemical Society 2014-11-25 2014-12-30 /pmc/articles/PMC4283935/ /pubmed/25423620 http://dx.doi.org/10.1021/bi501246v Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Hangasky, John A.
Gandhi, Hasand
Valliere, Meaghan A.
Ostrom, Nathaniel E.
Knapp, Michael J.
The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor
title The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor
title_full The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor
title_fullStr The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor
title_full_unstemmed The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor
title_short The Rate-Limiting Step of O(2) Activation in the α-Ketoglutarate Oxygenase Factor Inhibiting Hypoxia Inducible Factor
title_sort rate-limiting step of o(2) activation in the α-ketoglutarate oxygenase factor inhibiting hypoxia inducible factor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283935/
https://www.ncbi.nlm.nih.gov/pubmed/25423620
http://dx.doi.org/10.1021/bi501246v
work_keys_str_mv AT hangaskyjohna theratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT gandhihasand theratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT vallieremeaghana theratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT ostromnathaniele theratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT knappmichaelj theratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT hangaskyjohna ratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT gandhihasand ratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT vallieremeaghana ratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT ostromnathaniele ratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor
AT knappmichaelj ratelimitingstepofo2activationintheaketoglutarateoxygenasefactorinhibitinghypoxiainduciblefactor